The FDA has approved the first gene therapy that can restore hearing to people who were born with a rare form deafness.
Rob Stein is a Correspondent and Senior Editor at various public radio outlets. An award-winning science journalist with over 30 years of experience, he primarily covers health and medicine, focusing on the intersection of science, health, politics, and ethics, with particular attention to genetics, cancer research, and women's health issues. His work has been featured in numerous esteemed platforms, including NPR, WCBU-FM, and The Aspen Times.











